Company intelligence / Profile preview

Biopas

Bogotá D.C., Colombia

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Biopas is the leading Latin American specialty pharmaceutical company, focused on in-licensing, marketing, and selling innovative branded prescription products in areas such as CNS, immunology, dermatology, oncology, gastroenterology, rare, and specialty diseases. The entire product portfolio is in-licensed from global partners, focusing on differentiated, non-generic, non-branded generic drugs.[1][2][3][5]

Industry: Biotech

Partnerships

Multiple unnamed leading pharmaceutical and biotech companies for regional in-licensing and commercialization partnerships

Beyond the preview

Go deeper on Biopas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biopas.

Explore the full profile